Capricor Therapeutics (CAPR) Other Operating Expenses (2019 - 2026)
Capricor Therapeutics (CAPR) recorded quarterly Other Operating Expenses of -$81143.0 in Q1 2026, down 1085.26% quarter-over-quarter from -$6846.0 in Q3 2025, and up 46.15% on a YoY basis from -$55521.8 in Q1 2025.
Capricor Therapeutics (CAPR) Other Operating Expenses (2019 - 2026) Analysis & Trends
Capricor Therapeutics' Other Operating Expenses history runs 7 years deep, the most recent figure standing at -$81143.0 for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 46.15% year-over-year to -$81143.0; the TTM figure through Mar 2026 stood at -$87989.0 (up 93.23% YoY), while the FY2025 annual figure was -$157519.0, down 39.64% from the prior year.
- Other Operating Expenses was -$81143.0 for Q1 2026 at Capricor Therapeutics, down from -$6846.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $4769.0 in Q2 2024 to a low of -$1.1 million in Q3 2024.
- Historically, Other Operating Expenses has averaged -$158680.0 across 5 years, with a median of -$13649.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Other Operating Expenses plunged 21063.16% in 2024, then surged 99.4% in 2025.
- A 5-year view of Other Operating Expenses shows it stood at -$34266.0 in 2022, then surged by 98.09% to -$653.0 in 2023, then slumped by 1990.2% to -$13649.0 in 2024, then jumped by 49.84% to -$6846.0 in 2025, then plunged by 1085.26% to -$81143.0 in 2026.
- The last three Other Operating Expenses figures came in at -$81143.0 (Q1 2026), -$6846.0 (Q3 2025), and -$150673.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Capricor Therapeutics | 1.53 Bn | 1.26 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -81,143.00 |
| Sep 30, 2025 | -6,846.00 |
| Mar 31, 2025 | -150,673.00 |
| Dec 31, 2024 | -13,649.00 |
| Sep 30, 2024 | -1.14 Mn |
| Jun 30, 2024 | 4,769.00 |
| Dec 31, 2023 | -653.00 |
| Sep 30, 2023 | -5,388.00 |
| Dec 31, 2022 | -34,266.00 |
| Dec 31, 2021 | -36,467.00 |
| Sep 30, 2021 | 13,915.00 |
| Jun 30, 2021 | -2,725.00 |
| Mar 31, 2021 | -3,678.00 |
| Jun 30, 2019 | -2,720.00 |